Purchase Order HT001419P0022
- Not listed
- This firm fixed price purchase order was awarded by the Defense Health Agency to Illumina, Inc., a manufacturer of genomic sequencing and analysis instruments and reagents. The $119,937.50 contract is for the procurement of replacement laboratory equipment, specifically next-generation sequencing systems and associated consumables, to support the agency's biodefense research and diagnostics efforts. Illumina has previously been awarded prime contracts and subcontracts across various federal...
- This is a firm fixed-price purchase order contract awarded by the U.S. Army Medical Command to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions. The contract is for a SEQUENCING SYSTEM with a ceiling value of $1,084,390.80 and a period of performance that runs through November 22, 2020. The contract does not have a set-aside designation. Illumina has provided sequencing systems, reagents, and services to support genomic research and analysis for various federal...
- This is a firm fixed-price purchase order awarded by the Office of Acquisitions and Grants, a civilian agency, to Illumina, Inc., a manufacturer of genomic sequencing instruments and solutions. The contract is for $71,643.00 to provide service maintenance for an Illumina MiSeq sequencer. The award has no set-aside designation and the period of performance runs through June 10, 2024. Illumina has a history of providing sequencing systems and related services to various government agencies,...
- This is a $75,560 firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a manufacturer of genetic and genomic analysis equipment and reagents. The contract is for the delivery of various Illumina sequencing systems, consumables, and related support services. There is no set-aside designation for this contract. Illumina has a history of supporting genomic sequencing and analysis for federal agencies like the NIH, Centers for...
- This is a firm fixed-price purchase order worth $499,633.76 awarded by the Defense Health Agency to Illumina, Inc. for the procurement of a NEXTSEQ 550 SEQUENCING SYSTEM. The contract has no set-aside designation. Illumina has been a long-standing provider of sequencing instruments, reagents, and bioinformatics solutions to various federal agencies, including the NIH, CDC, USDA, and VA, to support genomic research and diagnostics. While this appears to be a standalone purchase order, Illumina...
- This is a firm fixed price purchase order contract awarded by the Defense Health Agency to Illumina, Inc. for the TRUSIGHT ONCOLOGY 500 BUNDLE. The contract has a ceiling value of $197,786.89 and a period of performance through September 30, 2024. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has provided similar products and services to various federal agencies in the past, including the National Institutes of Health, Centers for Disease Control,...
- This is a firm fixed price delivery order awarded by the National Institutes of Health (NIH) to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The $113,164.34 order is for the provision of sequencing systems, consumables, and maintenance services to support the agency's research and diagnostic needs. Illumina has a history of providing similar products and services to federal agencies like the NIH, Centers for Disease Control, and Department of...
- This firm fixed-price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. The $116,503.92 contract is for the delivery of undisclosed sequencing products and services to support the agency's mission. Illumina has an Indefinite Delivery Contract worth up to $3.3 million with the Navy for providing reagents and controls for various Illumina sequencing platforms used by the Naval...
- This is a firm fixed price delivery order awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $22,198.05 contract is for the provision of various Illumina sequencing systems, reagents, consumables, and related services to support genomic sequencing and analysis work. Illumina has a history of providing similar products and services to federal agencies like the NIH,...
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services (HHS) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $10,377.28, is for the purchase of unspecified Illumina sequencing systems, reagents, and consumables. The award has no set-aside designation. Illumina has been awarded multiple previous prime contracts and sub-awards from federal agencies like the NIH,...
This is a firm fixed price purchase order awarded by the Defense Health Agency to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $197,939.00 contract is for a testing and maintenance agreement for two pathology instruments. The contract has no set-aside designation. Through prior prime contract awards, Illumina has provided sequencing systems and related goods and services to support genomic research and analysis across various federal agencies, including the National Institutes of Health, Centers for Disease Control and Prevention, and Department of Veterans Affairs. Illumina also holds an Indefinite Delivery Contract with the Department of the Navy's Bureau of Medicine and Surgery to provide sequencing reagents and controls for instruments used to characterize biological threats.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $49.9k | 11/20/18 |